Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

PCOS treatment focuses on lifestyle changes and specific medications to manage symptoms and complications.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

New compounds may soon be tested to treat excessive hair growth in women.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Review finds no permanent solution for female hair loss.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Analog 23 is a promising compound for prostate cancer treatment.

Feathers are useful for researching growth, regeneration, and the effects of treatments like chemotherapy on hair loss.

New oral treatment, finasteride, effectively and safely treats common hair loss.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.